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In a short communication in this issue (Manser et al. 2012),
Christopher Miller’s group at the Institute of Psychiatry,
King’s College London present an elegant and convincing set
of experiments using molecular techniques to show that a
brain-enriched membrane-associated protein kinase, lemur
tyrosine kinase-2 (LMTK2), is directly phosphorylated by the
cyclin-dependent kinase-5/p35 and this event is sufficient for
LMTK2 to phosphorylate an abundant protein phosphatase,
PP1C. LMTK2 has been little studied to date and, despite its
name, is a kinase which phosphorylates serine or threonine
residues of protein substrates. The paper adds to the evidence
that this enzyme is a potentially important mediator posi-
tioned to integrate a number of intracellular signalling
pathways relevant to neurodegeneration.
While it had been previously established that PP1C was a
binding partner and substrate for LMTK2 (Wang and
Brautigan 2002), in the current paper the authors have
revealed, for the first time, the precise molecular interaction.
They have done this by first characterising the cdk5/p35
phosphorylation site of LMTK2 using mass spectrometric
techniques. Then they constructed a series of mutants of
LMTK2, namely mutating ser1418 to alanine, to block cdk5/
p35 phosphorylation (LMTK2S1418A), by mutating ser1418 to
aspartate to mimic a state of permanent phosphorylation,
(LMTK2S1418D) and also constructing a mutant lacking the
PP1C-interacting domain. In co-expression experiments, they
showed that LMTK2 allows cdk5/p35-dependent phosphor-
ylation of PP1C, and that this is reduced by co-transfection of
the LMTK2S1418A mutant incapable of being phosphorylated
and enhanced by the LMTK2S1418D mutant which mimics the
permanently phosphorylated enzyme.
Therefore, the group have established the biochemical
mechanism linking this substrate of cdk5/p35 with a protein
phosphatase PP1C (Figure 1). At the current time, the
implications of cdk5/p35-dependent LMTK2 phosphoryla-
tion on CNS function are not known, and the molecular tools
this group have developed should allow the functions to be
more fully characterised. As cdk5 itself is a critical mediator
of neuronal survival, its inhibition resulting in neuronal death
(Hisanaga and Endo 2010), it is possible that some of the
detrimental consequences of cdk5-inhibition are mediated
Fig. 1 Some molecular and functional interactions of Lemur tyrosine
kinase-2 (LMTK2). The N-terminus of LMT2K contains transmem-
brane domains allowing interaction with intracellular vesicles, including
early endosomes. The cdk5 activator, p35 and myosin VI tail region
bind to a central region of LMTK2 (within amino acid residues 567–
773). p35/cdk5 mediates phosphorylation of LMT2K at serine 1418.
Phosphorylated LMTK2 induces phosphorylation of protein phospha-
tase 1C (PP1C) at threonine 320. PP1C binds to LMTK2 at a tripeptide
motif (Valine Threonine Phenylalanine). Among CNS substrates for
PP1C is glycogen synthase kinase-3b (GSK3b): activation of LMTK2
results in reduced phosphorylation of GSK3b at Serine 9. Diagram
derived from data in Kesavapany et al. (2003), Chibalina et al.(2007)
and Manser et al. (2011, 2012).
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through loss of phosphorylation of LMTK2. In another
article published late last year, the authors link the
phosphorylation of PP1C by LMTK2 to further downstream
signalling events (Manser et al. 2011). In that paper, they
show that LMTK2, through PP1C, inhibits the phosphory-
lation of glycogen synthase kinase-3b (GSK3b) (Manser
et al. 2011). GSK3b is a protein kinase with numerous
functions, including an important role in neurodegenerative
disease (Bhat et al. 2004; Hooper et al. 2008). Thus, it
would be predicted that through inhibition of GSK3b,
LMTK2 has neuroprotective functions, and that loss of
function of LMTK2 may cause neurodegeneration. So far,
however, there is no direct experimental data published to
detail the role of LMTK2 in neurodegeneration. LMTK2
knockout mice are infertile caused by the inability to produce
sperm (Kawa et al. 2006), and although these mice are
reported to have no obvious histological abnormalities in the
CNS, no detailed analysis yet exists.
The location of LMTK2 is of importance, and poses
another mystery which is likely to be important in revealing
its function and role in neurodegeneration. While it is a
membrane protein, LMTK2 is not found highly expressed in
the plasma membrane, but instead in intracellular compart-
ments, particularly early endosomes (Kesavapany et al.
2003; Chibalina et al. 2007; Inoue et al. 2008). LMTK2
has a critical role in regulating conversion of early
endosomes to recycling endosomes, a role dependent on its
interaction with myosin VI (Chibalina et al. 2007). In this
regard, it is of interest that one of the first functions ascribed
to LMTK2 was nerve growth factor signalling (Kawa et al.
2004): retrograde transport of nerve growth factor signalling
complexes is critically dependent on formation of endo-
somes, followed by transport of signalling complexes
(Grimes et al. 1996; Harrington et al. 2011). In addition to
a role in endosomal trafficking, LMTK2’s functions suggest
a role in axonal transport. The authors have shown that
LMTK2-mediated dephosphorylation of GSK3b (via activa-
tion of PP1C) results in reduced phosphorylation (activation)
of a kinesin-1 light chain, a protein which allows the
transport of molecular cargoes, including signalling com-
plexes, along microtubules (Manser et al. 2011). Therefore,
LMTK2 may have a key role in endosomal and axonal
trafficking in numerous processes critical to neuronal health.
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